doi: 10.1016/0041-008x(73)90219-6.
Intestinal absorption of disodium ethane-1-hydroxy-1,1-diphosphonate (disodium etidronate) using a deconvolution technique
- PMID: 4197358
- DOI: 10.1016/0041-008x(73)90219-6
Item in Clipboard
Intestinal absorption of disodium ethane-1-hydroxy-1,1-diphosphonate (disodium etidronate) using a deconvolution technique
Toxicol Appl Pharmacol.
1973 Apr.
No abstract available
Similar articles
-
Ileal absorption of disodium ethane-1-hydroxy-1,1-diphosphonate (EHDP) and disodium dichloromethylene diphosphonate(C12 MDP) in the chick.Experientia. 1973 Sep 15;29(9):1110-1. doi: 10.1007/BF01946749. Experientia. 1973. PMID: 4200771 No abstract available.
-
Absorption of oral diphosphonate in normal subjects.Clin Endocrinol (Oxf). 1986 Jan;24(1):57-62. doi: 10.1111/j.1365-2265.1986.tb03254.x. Clin Endocrinol (Oxf). 1986. PMID: 3085989
-
Dose-dependent absorption of disodium etidronate.J Pharm Pharmacol. 1985 Jun;37(6):443-5. doi: 10.1111/j.2042-7158.1985.tb03035.x. J Pharm Pharmacol. 1985. PMID: 2862272
-
Metabolism of disodium ethane-1-hydroxy-1,1-diphosphonate (disodium etidronate) in the rat, rabbit, dog and monkey.Toxicol Appl Pharmacol. 1972 Apr;21(4):503-15. doi: 10.1016/0041-008x(72)90007-5. Toxicol Appl Pharmacol. 1972. PMID: 4625817 No abstract available.
-
Preliminary study of the treatment of nephrolithiasis (calcium stones) with diphosphonate.Metabolism. 1974 Dec;23(12):1167-73. doi: 10.1016/0026-0495(74)90033-x. Metabolism. 1974. PMID: 4372511 No abstract available.
Cited by
-
Etidronic acid. A review of its pharmacological properties and therapeutic efficacy in resorptive bone disease.Drugs Aging. 1994 Dec;5(6):446-74. doi: 10.2165/00002512-199405060-00006. Drugs Aging. 1994. PMID: 7858370 Review.
-
[Diphosphonate for the prevention of an increased ossification process].Klin Wochenschr. 1986 Jun 16;64(12):575-8. doi: 10.1007/BF01735322. Klin Wochenschr. 1986. PMID: 3090346 German. No abstract available.
-
Bisphosphonates in bone diseases.Pharm World Sci. 1998 Oct;20(5):206-13. doi: 10.1023/a:1008626026484. Pharm World Sci. 1998. PMID: 9820883 Review.
-
Bisphosphonates. Pharmacology and use in the treatment of tumour-induced hypercalcaemic and metastatic bone disease.Drugs. 1991 Dec;42(6):919-44. doi: 10.2165/00003495-199142060-00003. Drugs. 1991. PMID: 1724640 Review.
-
A comparison of the pharmacokinetics of 14C-labelled APD and 99mTc-labelled APD in the mouse.Calcif Tissue Int. 1988 Aug;43(2):125-7. doi: 10.1007/BF02555158. Calcif Tissue Int. 1988. PMID: 3142665
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources